Evaluate the biodistribution of HyperMabs protein biologics therapeutics

HyperMabs is a biopharmaceutical company that designs and develops innovative therapeutics targeting lung diseases. HyperMabs is currently evaluating a drug candidate developed using in-silico methods to target lung disease. For this project, we aim to study the biodistribution of HyperMabs therapeutic, currently in its pre-clinical stage designed to treat several lung diseases. To achieve this, […]

Read More